BioCentury
ARTICLE | Company News

Abbott's AbbVie spinout debuts

January 3, 2013 2:18 AM UTC

The AbbVie Inc. (NYSE:ABBV) pharmaceutical business spinout of Abbott Laboratories (NYSE:ABT) debuted on Wednesday as a separate public company. Abbott retains Abbott's name and houses the pharma's ge...